NEW YORK (Reuters Health) – An analysis of epidemiologic data confirms that the incidence of second primary malignancies is increased after external beam radiotherapy (EBRT) for stage I…
NEW YORK (Reuters Health) – The likelihood of refractory ischemia developing in patients with non-ST-segment elevation acute coronary syndrome is reduced if they undergo early rather than deferred…
NEW YORK (Reuters Health) – The high risk of fractures in the first year after solid organ transplantation can be roughly halved with bisphosphonate or vitamin D treatment,…
NEW YORK (Reuters Health) – Delivery of the antispasmodic, antimuscarinic agent oxybutynin in a topical gel relieves urinary symptoms and improves health-related quality of life in women with…
NEW YORK (Reuters Health) – Despite having a favorable effect on cytokine levels, perioperative methylprednisolone does not reduce the incidence of lung injury after pulmonary thromboendarterectomy (PTE), according…
NEW YORK (Reuters Health) – In patients with acute coronary syndrome undergoing percutaneous coronary intervention (PCI) prasugrel shows the most favorable benefit-to-risk ratio in the core group of…
NEW YORK (Reuters Health) – Intra-aortic balloon counterpulsation (IABC) to augment blood flow before and for 12 hours after percutaneous coronary intervention (PCI) does not reduce infarct size…
NEW YORK (Reuters Health) – New clinical guidelines from the American Academy of Pediatrics (AAP) recommend a less invasive approach to the diagnosis and management of urinary tract…
NEW YORK (Reuters Health) – Beta-blockers improve all-cause mortality in patients with chronic kidney disease (CKD) and heart failure, according to a report in the September 6th Journal…
NEW YORK (Reuters Health) – In low-risk women, exercise treadmill testing (ETT) gives similar results to exercise myocardial perfusion imaging (MPI) and is less expensive, researchers report in…